Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Curelab Veterinary
AddedFeb 17, 2024
UpdatedJun 18, 2026
Curelab Veterinary

Curelab Veterinary

Angel

Curelab Veterinary: Specialized pet therapy provider for breast cancer in dogs and cats.

HQ
Boston, MA, US
Founded
2020
Overview
Compare
Fundraising
Employees
Website

Curelab Veterinary, founded with a mission to help pets live longer, healthier, and happier lives, focuses on treating breast cancer in dogs and cats. The company’s core vision is to address the rising incidence of cancer and chronic inflammatory diseases in pets, which have become more prevalent as pets' lifespans increase. Curelab Veterinary offers ElenaVet®, a gene therapy designed to enhance the body's anticancer immune response, positioning itself in the specialized market of veterinary oncology.

Notable affiliated individuals and investors include experts in veterinary medicine and biotechnology, although specific names are not provided. Key achievements include successful comparative medicine studies demonstrating the efficacy of ElenaVet® in treating breast cancer in dogs. The overall impact of Curelab Veterinary is significant, offering innovative solutions that improve the quality of life for pets suffering from cancer, thus addressing a critical need in the veterinary healthcare market.

Curelab Veterinary - Similar Companies

Elias Animal Health logo

Elias Animal Health

Vetigenics logo

Vetigenics

vetigenics.com

FidoCure® logo

FidoCure®

fidocure.com

MySimplePetLab logo

MySimplePetLab

mysimplepetlab.com

VetDC logo

VetDC

Embark Veterinary logo

Embark Veterinary

embarkvet.com

Bond Vet logo

Bond Vet

bondvet.com

Leah Labs logo

Leah Labs

leahlabs.com

Curelab Oncology logo

Curelab Oncology

Gallant Pet logo

Gallant Pet

gallant.com

Dr.Tail logo

Dr.Tail

drtail.us

PepiPets logo

PepiPets

pepipets.com

KwikVet logo

KwikVet

kwikvet.com

MedVet logo

MedVet

medvetforpets.com

Thurlow Veterinary Services logo

Thurlow Veterinary Services

thurlowvet.com

Curelab Veterinary - Quick Facts

Who are Curelab Veterinary's competitors?

Companies similar to Curelab Veterinary include Elias Animal Health, Vetigenics, FidoCure® and MySimplePetLab.

When was Curelab Veterinary founded?

Curelab Veterinary was founded in 2020.

Where is Curelab Veterinary's headquarters located?

Curelab Veterinary's headquarters is located in Boston, MA, US.

When was Curelab Veterinary's last funding round?

Curelab Veterinary's most recent funding round was for $2.5M (USD) in November 2022.

How much has Curelab Veterinary raised to-date?

As of Nov 21, 2022, Curelab Veterinary has raised a total of $2.5M (USD).

How many employees does Curelab Veterinary have?

Curelab Veterinary has 5 employees as of Feb 5, 2024.

Curelab Veterinary - Classification

Ownership
  • Venture Capital
Technology
  • Biotech
  • Gene Therapy
Geographic Exposure
  • United States
Revenue
  • Recurring
Customer
  • Consumers
Main Product
  • Pet Therapy
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541940Veterinary Services
  • 541000Professional, Scientific, and Technical Services
  • 541900Other Professional, Scientific, and Technical Services
SIC
  • 700Agricultural Services
  • 740Veterinary Services
Show 9 more industry codes
NAICS
  • 560000Administrative and Support and Waste Management and Remediation Services
  • 620000Health Care and Social Assistance
  • 561000Administrative and Support Services
SIC
  • 7300Business Services
  • 8000Health Services
  • 7380Miscellaneous Business Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 7389Business Services, Not Elsewhere Classified
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified